Spyre Therapeutics
SYRE
SYRE
26 hedge funds and large institutions have $24.4M invested in Spyre Therapeutics in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
36% less capital invested
Capital invested by funds: $38M → $24.4M (-$13.6M)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$175K | |
| 2 | +$149K | |
| 3 | +$90.4K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$62.8K |
| 5 |
SIM
Spark Investment Management
New York
|
+$52K |
Top Sellers
| 1 | -$2.15M | |
| 2 | -$321K | |
| 3 | -$230K | |
| 4 |
Goldman Sachs
New York
|
-$98.2K |
| 5 |
TG
TLP Group
Evanston,
Illinois
|
-$76K |